Consequently, the next steps are immunohistochemical staining of tissue samples from further organs and tumors, especially low-grade gliomas, and detection of myotrophin by immunostaining and RNA analysis to assess whether LuzP6 and myotrophin are translated together, or even expressed as one fusion protein. This evidence concerns the gene MTPN and glioma.